Learn how uACR and eGFR uncover hidden CKD, sharpen cardiovascular risk, and guide patient-friendly conversations for earlier, smarter care.

Experts explain how uACR and eGFR testing reveals hidden CKD, links to heart risk, and guides early, patient-centered care.

CKD guidelines agree: use eGFR plus UACR for KDIGO staging, but screening lags—see how teams and EHRs close the gap.

Why CKD screening lags despite aligned KDIGO, ADA and hypertension guidance—use eGFR plus UACR staging and EHR prompts to act earlier.

Clinicians across specialties share responsibility for early kidney disease screening—use UACR and eGFR at every touchpoint to prevent patients slipping through cracks.

Learn how UACR testing complements eGFR, reveals hidden kidney and cardiovascular risk, and uses a color-coded heat map to guide patient communication and referrals.

Learn why pairing eGFR with urine albumin-creatinine ratio improves CKD screening, avoids missed diagnoses, and guides follow-up care.

Why uACR urine testing lags: incentives, workflow gaps, and silos—and how KDIGO staging strengthens kidney and cardiovascular risk conversations.

Clinicians rethink cardio-renal care: educate teams, streamline workflows, expand screening via pharmacists and EHRs, and prioritize prevention over dialysis.

Learn how KDIGO risk staging and urine ACR guide CKD management, triage, and timely nephrology referral when red flags appear.

Explore the four-pillars approach to slowing kidney disease—max dose ACE/ARB, add SGLT2, MRA, GLP‑1—plus access and team-based tips.

Heart failure playbook reshapes CKD care: early combo therapies, right dosing, and smart uACR/eGFR follow-up to boost adherence.

See how UACR trends motivate patients, guide shared decisions, and tailor therapies to slow CKD while lowering cardiovascular risk.

Learn how uACR and eGFR tracking, EHR prompts, and team-based titration streamline early CKD care and reduce cardiovascular risk.